US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Novartis AG

105.85

-6.4100-5.71%

Post-market: 104.25-1.5973-1.51%19:52 EDT

Volume:3.53M

Turnover:380.20M

Market Cap:200.86B

PE:18.03

High:109.91

Open:109.50

Low:105.62

Close:112.26

Loading ...

Overview Company News Filings

Pharma Stock Roundup: FDA Nod to SNY, AZN & NVS, JNJ Talc Suits Failure

Novartis Secures Third FDA Approval For Its Kidney Disease Portfolio In One Year

Novartis Gets FDA Accelerated Approval for Vanrafia

MT Newswires Live

Big Pharma Stocks Rise After Exclusion From U.S. Tariffs -- Market Talk

Novartis gets FDA accelerated approval for Vanrafia

Big Pharma Avoids Worst-Case Tariff Scenario -- WSJ

APLS' Empaveli sNDA for 2 Rare Kidney Diseases Gets FDA Priority Tag

Novartis AG Falls Monday, Outperforms Market

JNJ's Rybrevant-Lazcluze Combo Outshines AZN's Tagrisso in Lung Cancer

Alphabet's Isomorphic Labs Unit Raises $600 Million for AI-Based Drug Development

MT Newswires Live

Novartis Gets FDA Approval for Expanded Pluvicto Indication

MT Newswires Live

FDA approves Novartis radioligand therapy Pluvicto for earlier use in mCRPC

FDA approves Novartis radioligand therapy Pluvicto® for earlier use before chemotherapy in PSMA-positive metastatic castration-resistant prostate cancer

Novus Holdings Says TRP Withdraws Approval Of Co's Firm Intention Announcement

Here's Why Novartis (NVS) is a Strong Value Stock

Novartis AG Rises Thursday, Outperforms Market

Novartis to present new data at AAN, including seven-year disability outcomes and safety analysis of Kesimpta® in people with relapsing multiple sclerosis

Novartis AG Falls Monday, Underperforms Market

Alnylam Gets FDA Nod for Expanded Use of Amvuttra in Cardiomyopathy

Pharma Stock Roundup: PFE's Final Haleon Stake Sale, AZN, SNY M&A Deals

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/NVS/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"NVS","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NVS\",,,,,undefined,":{"symbol":"NVS","market":"US","secType":"STK","nameCN":"Novartis AG","latestPrice":105.85,"timestamp":1743796800000,"preClose":112.26,"halted":0,"volume":3526297,"hourTrading":{"tag":"盘后","latestPrice":104.2527,"preClose":105.85,"latestTime":"19:52 EDT","volume":13789,"amount":1459302.6414,"timestamp":1743810777448},"delay":0,"floatShares":1805549286,"shares":1897580618,"eps":5.87,"marketStatus":"Market Closed","change":-6.41,"latestTime":"04-04 16:00:00 EDT","open":109.5,"high":109.91,"low":105.615,"amount":380204214.12496,"amplitude":0.038259,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":5.87,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Market Trading","tradingStatus":1,"beginTime":1744012800000},"marketStatusCode":7,"adr":1,"adrRate":1,"exchange":"NYSE","adjPreClose":112.26,"dividendRate":0.036489,"preHourTrading":{"tag":"盘前","latestPrice":109.51,"preClose":112.26,"latestTime":"09:29 EDT","volume":534276,"amount":59091443.847720005,"timestamp":1743773390099},"postHourTrading":{"tag":"盘后","latestPrice":104.2527,"preClose":105.85,"latestTime":"19:52 EDT","volume":13789,"amount":1459302.6414,"timestamp":1743810777448},"volumeRatio":1.3434794386671014,"impliedVol":0.4016,"impliedVolPercentile":0.996},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NVS\",,,,,undefined,":{"symbol":"NVS","floatShares":1805549286,"roa":"10.09%","roe":"26.28%","lyrEps":5.916419,"volumeRatio":1.3434794386671014,"shares":1897580618,"dividePrice":3.862367,"high":109.91,"amplitude":0.038259,"preClose":112.26,"low":105.615,"week52Low":92.35,"pbRate":"4.56","psRate":"3.88","week52High":120.92,"institutionHeld":0.0333,"latestPrice":105.85,"eps":5.87,"divideRate":0.036489,"volume":3526297,"delay":0,"ttmEps":5.87,"open":109.5,"prevYearClose":97.31,"prevWeekClose":112.57,"prevMonthClose":111.48,"prevQuarterClose":111.48,"fiveDayClose":112.57,"twentyDayClose":115.57,"sixtyDayClose":98.98,"earningDate":1745856000000,"earningTime":"盘前"},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"NVS\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2524784382","title":"Pharma Stock Roundup: FDA Nod to SNY, AZN & NVS, JNJ Talc Suits Failure","url":"https://stock-news.laohu8.com/highlight/detail?id=2524784382","media":"Zacks","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524784382?lang=en_us&edition=fundamental","pubTime":"2025-04-04 21:46","pubTimestamp":1743774360,"startTime":"0","endTime":"0","summary":"This week, the FDA approved Sanofi’s SNY hemophilia therapy, fitusiran, Novartis’ NVS Vanrafia for the reduction of proteinuria in adults with primary immunoglobulin A nephropathy and the expanded use of AstraZeneca’s AZN blockbuster cancer drug, Imfinzi. J&J’s JNJ bankruptcy strategy to settle talc lawsuits failed for the third time. The European Commission approved Pfizer’s PFE respiratory syncytial virus vaccine, Abrysvo, for use in adults aged 18 through 59 years.Here's a recap of the week’s most important stories.Texas Court Rejects J&J’s Bankruptcy Attempt to End Talc Suits. A bankruptcy court in Texas rejected J&J’s proposed bankruptcy plan to settle claims related to its talc lawsuits for the third time. In September, J&J, via a subsidiary called Red River Talc, filed for voluntary bankruptcy in the Southern District of Texas after it received the support of around 83% of current claimants for the proposed bankruptcy plan, which was above the 75% required by the U.S. bankruptcy","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/pharma-stock-roundup-fda-nod-134600557.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["PFE","LU0320765992.SGD","LU2129689431.USD","BK4585","LU2133065610.SGD","LU1585245621.USD","LU0306807586.USD","LU2592432038.USD","LU2129689605.HKD","NVS","IE00BLSP4239.USD","IE00BSNM7G36.USD","AZN","LU0889566641.SGD","LU0912757837.SGD","BK4532","LU0985320562.USD","LU2112291526.USD","LU2602419157.SGD","LU2430703178.SGD","LU0058720904.USD","LU1894683264.USD","LU1280957306.USD","LU1732799900.SGD","LU1778281490.HKD","IE00B1BXHZ80.USD","LU0114720955.EUR","LU0868494617.USD","LU1267930813.SGD","SG9999001440.SGD","BK4599","LU0345770308.USD","LU1261432733.SGD","CHMP","LU0070302665.USD","LU0345770993.USD","LU1244550221.USD","LU1430594728.SGD","LU1674673691.USD","BK4533","IE00B3PB1722.GBP","SG9999001176.USD","IE00B2B36J28.USD","SNY","IE00BJT1NW94.SGD","IE00BVYPNW00.USD","SG9999013999.USD","LU0225284248.USD","LU0289739699.SGD","JNJ"],"gpt_icon":1},{"id":"2524293880","title":"Novartis Secures Third FDA Approval For Its Kidney Disease Portfolio In One Year","url":"https://stock-news.laohu8.com/highlight/detail?id=2524293880","media":"Benzinga","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524293880?lang=en_us&edition=fundamental","pubTime":"2025-04-04 00:10","pubTimestamp":1743696643,"startTime":"0","endTime":"0","summary":"The U.S. Food and Drug Administration  on Wednesday granted accelerated approval for Novartis AG’s  Vanrafia  to reduce proteinuria in adults with primary immunoglobulin A nephropathy  at risk of rapid disease progression.Vanrafia is a once-daily, non-steroidal, oral treatment that can be added to supportive care, including a renin-angiotensin system inhibitor with or without a sodium-glucose co-transporter-2 inhibitor.Vanrafia was granted accelerated approval based on a prespecified interim analysis of the Phase 3 ALIGN study measuring the reduction of proteinuria at 36 weeks compared to placebo.Also Read: FDA Reviews Kidney Disease Drug From Apellis Pharmaceuticals. It has not been established whether Vanrafia slows kidney function decline in patients with IgAN.The continued approval of Vanrafia may be contingent upon verifying clinical benefit from the ongoing Phase 3 ALIGN study evaluating whether Vanrafia slows disease progression as measured by estimated glomerular filtration rat","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/novartis-secures-third-fda-approval-161043441.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Novartis Secures Third FDA Approval For Its Kidney Disease Portfolio In One Year","news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0070302665.USD","LU0208291251.USD","IE00BJJMRZ35.SGD","BK4578","NVS","BK4532","IE00BJT1NW94.SGD","LU0211331839.USD","IE00BFTCPJ56.SGD","IE00B4R5TH58.HKD","IE0002141913.USD","IE0009355771.USD","IE00B2B36J28.USD","BK4585","BK4007","BK4588","LU0320765489.SGD"],"gpt_icon":0},{"id":"2524128499","title":"Novartis Gets FDA Accelerated Approval for Vanrafia","url":"https://stock-news.laohu8.com/highlight/detail?id=2524128499","media":"MT Newswires Live","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524128499?lang=en_us&edition=fundamental","pubTime":"2025-04-03 16:41","pubTimestamp":1743669711,"startTime":"0","endTime":"0","summary":"Novartis  said late Wednesday the US Food and Drug Administration granted accelerated approval for Vanrafia to reduce proteinuria in adults with primary immunoglobulin A nephropathy, or IgAN, at risk of rapid disease progression.IgAN is a progressive, rare kidney disease.Data from an ongoing phase III showed that Vanrafia achieved proteinuria reduction of about 36%, compared with placebo, with improvements seen at week six and sustained through week 36, as well as favorable safety, the company said.It has not been established whether Vanrafia slows kidney function decline in patients with IgAN, the company said, adding that the continued approval could depend on longer term data from the ongoing phase III study, which will evaluate whether Vanrafia slows disease progression based on estimated glomerular filtration rate decline, with results expected in 2026.Novartis shares were up 1.3% in recent premarket activity Thursday.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4578","BK4585","LU0070302665.USD","IE00B4R5TH58.HKD","LU0208291251.USD","BK4007","BK4532","IE00BJT1NW94.SGD","NVS","IE00B2B36J28.USD","LU0320765489.SGD","IE00BJJMRZ35.SGD","LU0211331839.USD","IE0002141913.USD","BK4588","IE0009355771.USD","IE00BFTCPJ56.SGD"],"gpt_icon":0},{"id":"2524832162","title":"Big Pharma Stocks Rise After Exclusion From U.S. Tariffs -- Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2524832162","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524832162?lang=en_us&edition=fundamental","pubTime":"2025-04-03 15:51","pubTimestamp":1743666660,"startTime":"0","endTime":"0","summary":"0751 GMT - Big Pharma stocks are up after U.S. President Trump exempted pharmaceuticals for now from his reciprocal tariffs on global imports. \"It is still somewhat unclear whether the broader reaching 10% baseline tariffs could still be levied against imported drugs and vaccines, in our view,\" Shore Capital analyst Sean Conroy says in a note. Likewise, Bryan Garnier Research analysts say in a note that the pharma industry is left uncertain about an actual tariff risk given Trump's mixed remarks that drugmakers \"will come roaring back to the U.S., because if they don't, they got a big tax to pay.\" Novartis and Sanofi are up 0.6% and 0.3%, respectively. The U.K's AstraZeneca and GSK rose 1% and 1.6%, respectively. Swiss pharma giant Roche is down 2.3% after its multiple-sclerosis drug Ocrevus failed to meet its primary endpoint. ","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1829250122.USD","LU0320765992.SGD","LU2417539215.USD","LU0889565916.HKD","LU0211331839.USD","IE00BFTCPJ56.SGD","RHHBY","AZN","BK4578","IE0002141913.USD","LU0109394709.USD","IE00B2B36J28.USD","BK4568","LU2236285917.USD","LU0320765489.SGD","LU2462157665.USD","LU0070302665.USD","BK4532","SNY","BK4007","IE0009355771.USD","BK4588","GSK","IE00BJJMRZ35.SGD","BK4585","03165","IE00BFXG1179.USD","IE00B4R5TH58.HKD","IE00BJT1NW94.SGD","NVS","GSK.UK","LU0208291251.USD","LU2456880835.USD"],"gpt_icon":0},{"id":"2524142759","title":"Novartis gets FDA accelerated approval for Vanrafia","url":"https://stock-news.laohu8.com/highlight/detail?id=2524142759","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524142759?lang=en_us&edition=fundamental","pubTime":"2025-04-03 08:50","pubTimestamp":1743641410,"startTime":"0","endTime":"0","summary":"Novartis (NVS) “announced the FDA has granted accelerated approval for Vanrafia, or atrasentan, a potent and selective endothelin A receptor antago...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/novartis-gets-fda-accelerated-approval-for-vanrafia?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/novartis-gets-fda-accelerated-approval-for-vanrafia?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0208291251.USD","BK4578","BK4588","IE00B2B36J28.USD","IE0009355771.USD","IE00BJJMRZ35.SGD","LU0070302665.USD","BK4007","BK4585","IE00BFTCPJ56.SGD","IE0002141913.USD","BK4532","IE00B4R5TH58.HKD","IE00BJT1NW94.SGD","LU0320765489.SGD","NVS","LU0211331839.USD"],"gpt_icon":0},{"id":"2524406442","title":"Big Pharma Avoids Worst-Case Tariff Scenario -- WSJ","url":"https://stock-news.laohu8.com/highlight/detail?id=2524406442","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524406442?lang=en_us&edition=fundamental","pubTime":"2025-04-03 06:03","pubTimestamp":1743631380,"startTime":"0","endTime":"0","summary":"Drugmakers breathed a sigh of relief Wednesday after President Trump didn't announce pharmaceutical tariffs.Plus, language in the executive order indicated medicines were exempted from the reciprocal tariffs that Trump did announce.Drugmakers were combing over the executive order to clarify the exemption language in the executive order and to make sure they won't be hit by any other tariff provisions, such as the 10% \"baseline\" tariff.President Trump had said he was going to impose pharmaceutical tariffs at some point-a move that could have affected branded medicines imported from countries like Ireland as well as the many generic drugs made in India.Shares of drugmakers in the U.S. and overseas varied in after-market trading, reflecting the lack of clarity.This item is part of a Wall Street Journal live coverage event. The full stream can be found by searching P/WSJL .","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0795875169.SGD","LU1720051017.SGD","SG9999002232.USD","SG9999014898.SGD","LLY","LU1551013425.SGD","LU0225771236.USD","LU0114720955.EUR","LU0943347566.SGD","JNJ","LU1162221912.USD","LU0882574139.USD","BK4504","IE00B42XCP33.USD","LU1674673691.USD","LU0208291251.USD","LU0345770993.USD","LU0170899867.USD","LU2063271972.USD","LU2360106947.USD","LU1778281490.HKD","GB00BDT5M118.USD","LU0471298694.HKD","LU1868836914.USD","IE00BVYPNV92.GBP","IE00B19Z3B42.SGD","LU0320765489.SGD","LU2324357040.USD","NVS","IE00BJLML261.HKD","IE000M9KFDE8.USD","LU1066053197.SGD","LU0058720904.USD","03165","LU0203202063.USD","LU0471298777.SGD","LU2237443465.HKD","LU2461242641.AUD","LU0234572021.USD","RHHBY","LU2361045086.USD","LU1989771016.USD","LU2237443622.USD","LU2361044949.HKD","PFE","LU0106261372.USD","LU1883839398.USD","LU0792757196.USD","LU0466842654.USD"],"gpt_icon":1},{"id":"2524581497","title":"APLS' Empaveli sNDA for 2 Rare Kidney Diseases Gets FDA Priority Tag","url":"https://stock-news.laohu8.com/highlight/detail?id=2524581497","media":"Zacks","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524581497?lang=en_us&edition=fundamental","pubTime":"2025-04-02 21:11","pubTimestamp":1743599460,"startTime":"0","endTime":"0","summary":"A filing accepted under the regulatory body’s Priority Review pathway reduces the review period to six months from the standard 10 months. This status is awarded to marketing applications for medicines intended to treat serious conditions and that, if approved, would offer a substantial improvement in safety, effectiveness, prevention, or diagnosis of such conditions.A final decision from the FDA is expected on July 28, 2025.Please note that Empaveli is approved in the United States for the treatment of paroxysmal nocturnal hemoglobinuria . The drug is also approved in Europe under the brand name Aspaveli for the same indication.Year to date, shares of Apellis have plunged 28.9% against theindustry’s 2.4% growth.In the VALIANT study, Empaveli was overall well-tolerated with a consistent safety profile. Adverse events were mostly mild to moderate in severity.Novartis recently announced that the FDA has approved Fabhalta for a third indication, C3G, to reduce proteinuria.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/apls-empaveli-snda-2-rare-131100793.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IE00B4R5TH58.HKD","CORT","APLS","IE00BJJMRZ35.SGD","BK4588","BK4585","LU0208291251.USD","LU0320765489.SGD","BAYRY","LU0566484027.USD","LU1559883803.SGD","IE0002141913.USD","BK4578","LU1093756168.USD","BK4007","BK4532","IE00B2B36J28.USD","LU0211331839.USD","IE0009355771.USD","IE00BJT1NW94.SGD","LU1093756325.SGD","LU0070302665.USD","NVS","BK4505","BK4139","IE00BFTCPJ56.SGD"],"gpt_icon":0},{"id":"2524922126","title":"Novartis AG Falls Monday, Outperforms Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2524922126","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524922126?lang=en_us&edition=fundamental","pubTime":"2025-04-01 00:15","pubTimestamp":1743437700,"startTime":"0","endTime":"0","summary":"This article was automatically generated using Dow Jones technology.Shares of Novartis AG  slipped 0.8% to CHF97.84 Monday on what proved to be an overall negative trading session for the stock market, with the Swiss SMI Index  falling 1.9% to 12,598.12.The stock's fall snapped a two-day winning streak.Novartis AG closed CHF4.88 below its 52-week high of CHF102.72, which the company reached on September 2, 2024.Trading volume was 4,532,307, compared to the 50-day average trading volume of 4,113,673.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVS","AG"],"gpt_icon":0},{"id":"2523792991","title":"JNJ's Rybrevant-Lazcluze Combo Outshines AZN's Tagrisso in Lung Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2523792991","media":"Zacks","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523792991?lang=en_us&edition=fundamental","pubTime":"2025-03-31 21:40","pubTimestamp":1743428400,"startTime":"0","endTime":"0","summary":"J&J JNJ recently reported new positive data from the phase III MARIPOSA study, which compared the combination of Rybrevant and Lazcluze against AstraZeneca’s AZN Tagrisso in first-line EGFR-mutated non-small cell lung cancer .Data from the study suggests that the Rybrevant-Lazcluze combo significantly extends overall survival  in NSCLC patients with EGFR exon 19 deletions  or exon 21 L858R substitution  mutations.We remind investors that the MARIPOSA study already achieved its primary endpoint of statistically significant and clinically meaningful improvement in progression-free survival. Based on this data, J&J secured approval for the Rybrevant-Lazcluze combo in the above indication in the United States and European Union  last year.J&J Boasts Rybrevant-Lazcluze Combo as Next Standard of Care. Rybrevant also received approval for a third indication in the United States. Last year, the FDA approved the combination of Rybrevant and chemotherapy  for the first-line treatment of patients","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/jnjs-rybrevant-lazcluze-combo-outshines-134000871.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU1221951046.USD","LU2417539215.USD","BK4533","IE00B19Z3581.USD","LU1674673428.USD","BK4588","BK4568","LU2236285917.USD","SG9999002232.USD","LU0889565916.HKD","LU1066051498.USD","LU0320765646.SGD","LU1162221912.USD","BK4581","LU2089984988.USD","LU0058720904.USD","BK4534","IE00B19Z3B42.SGD","LU0208291251.USD","IE00B7SZLL34.SGD","IE00B3T34201.USD","LU0345769631.USD","LU1929549753.HKD","AZN","LU0203347892.USD","LU1221951129.SGD","LU0912757837.SGD","BK4532","LU1057294990.SGD","LU0320765489.SGD","LU2468319806.SGD","NVS","LU1778281490.HKD","LU1914381329.SGD","LU1894683348.USD","LU1935042991.SGD","IE00BFTCPJ56.SGD","LU0889566641.SGD","JNJ","LU1023059063.AUD","LU0122379950.USD","IE0034235303.USD","LU1261432733.SGD","IE00B2B36J28.USD","BK4585","LU1059921491.USD","LU2430703251.USD","LU0211331839.USD","LU1244550494.USD","IE00BJT1NW94.SGD"],"gpt_icon":0},{"id":"2523944917","title":"Alphabet's Isomorphic Labs Unit Raises $600 Million for AI-Based Drug Development","url":"https://stock-news.laohu8.com/highlight/detail?id=2523944917","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523944917?lang=en_us&edition=fundamental","pubTime":"2025-03-31 21:09","pubTimestamp":1743426567,"startTime":"0","endTime":"0","summary":"Alphabet's  artificial intelligence-based drug discovery unit Isomorphic Labs said Monday it raised $600 million in its first external funding round to develop its AI drug design engine and support drug candidates into clinical testing.The investment, led by Thrive Capital with participation from GV and Alphabet, is expected to support AI research, the company said, adding that it has internal drug discovery programs in oncology and immunology, as well as collaborations with Eli Lilly  and Novartis .Isomorphic Labs said it also plans to expand its workforce.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1868836757.USD","IE00B3S45H60.SGD","LU0965509010.AUD","LU0426412945.USD","LU0345774391.USD","LU1720051108.HKD","USJW.SI","GB00BDT5M118.USD","BK4578","GOOGL","LU1670628061.USD","LU1791710400.SGD","LU2756315318.SGD","LU0208291251.USD","LLY","IE00BMPRXN33.USD","LU1043141123.HKD","LU0985320562.USD","LU0672654240.SGD","LU2360106947.USD","LU0557290698.USD","IE00BJTD4N35.SGD","IE00BFSS8Q28.SGD","LU0048584097.USD","IE00BYQQ9H92.USD","LU2168563687.JPY","LU2361044949.HKD","BK4077","GOOG","LU0708995401.HKD","LU1116320737.USD","LU0820561818.USD","LU0109391861.USD","LU1868837136.USD","LU1496350171.SGD","LU2362541273.HKD","SG9999013999.USD","LU0267386448.USD","LU1023059063.AUD","LU0215105999.USD","LU1496350502.SGD","BK4576","LU1303367103.USD","LU0029864427.USD","LU2552382058.USD","LU0302445910.USD","NVS","LU1629891620.HKD","LU0289941410.SGD","LU0175139822.USD"],"gpt_icon":1},{"id":"2523867526","title":"Novartis Gets FDA Approval for Expanded Pluvicto Indication","url":"https://stock-news.laohu8.com/highlight/detail?id=2523867526","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523867526?lang=en_us&edition=fundamental","pubTime":"2025-03-29 01:46","pubTimestamp":1743184006,"startTime":"0","endTime":"0","summary":"Novartis  said Friday the US Food and Drug Administration has approved its radioligand therapy Pluvicto for earlier use before chemotherapy in prostate cancer patients.The new indication allows the use in patients with metastatic castration-resistant prostate cancer who have been treated with an androgen receptor pathway inhibitor therapy and are considered appropriate to delay chemotherapy, Novartis said.The approval triples the number of patient population eligible to receive Pluvicto, the company said.Price: 112.29, Change: +0.89, Percent Change: +0.80","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0208291251.USD","BK4578","BK4588","IE00B2B36J28.USD","IE0009355771.USD","IE00BJJMRZ35.SGD","LU0070302665.USD","BK4007","BK4585","IE00BFTCPJ56.SGD","IE0002141913.USD","BK4532","IE00B4R5TH58.HKD","IE00BJT1NW94.SGD","LU0320765489.SGD","NVS","LU0211331839.USD"],"gpt_icon":0},{"id":"2523683108","title":"FDA approves Novartis radioligand therapy Pluvicto for earlier use in mCRPC","url":"https://stock-news.laohu8.com/highlight/detail?id=2523683108","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523683108?lang=en_us&edition=fundamental","pubTime":"2025-03-29 01:00","pubTimestamp":1743181210,"startTime":"0","endTime":"0","summary":"Novartis (NVS) announced that the Food and Drug Administration approved Pluvicto for patients with prostate-specific membrane antigen-positive meta...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/fda-approves-novartis-radioligand-therapy-pluvicto-for-earlier-use-in-mcrpc?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/fda-approves-novartis-radioligand-therapy-pluvicto-for-earlier-use-in-mcrpc?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0070302665.USD","LU0208291251.USD","IE00BJJMRZ35.SGD","BK4578","NVS","BK4532","IE00BJT1NW94.SGD","LU0211331839.USD","IE00BFTCPJ56.SGD","IE00B4R5TH58.HKD","IE0002141913.USD","IE0009355771.USD","IE00B2B36J28.USD","BK4585","BK4007","BK4588","LU0320765489.SGD"],"gpt_icon":0},{"id":"2523856256","title":"FDA approves Novartis radioligand therapy Pluvicto® for earlier use before chemotherapy in PSMA-positive metastatic castration-resistant prostate cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2523856256","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523856256?lang=en_us&edition=fundamental","pubTime":"2025-03-29 00:52","pubTimestamp":1743180720,"startTime":"0","endTime":"0","summary":"New indication approximately triples eligible patient population, allowing Pluvicto to be used after one androgen receptor pathway inhibitor  and now before chemotherapy. Pluvicto significantly reduced risk of progression or death by 59% and more than doubled median radiographic progression-free survival  vs. change in ARPI in Phase III PSMAfore trial*. Approximately half of patients do not live long enough to receive a second treatment for mCRPC, highlighting need for earlier use of effective therapies with demonstrated tolerability1. Multiple RLT manufacturing facilities in US fully meet supply needs for expanded indication, with industry-leading infrastructure to accelerate delivery of RLTs to patients. Basel, March 28, 2025 – Novartis announced today that the US Food and Drug Administration  approved Pluvicto  for patients with prostate-specific membrane antigen -positive metastatic castration-resistant prostate cancer  who have been treated with an androgen receptor pathway inhibi","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/fda-approves-novartis-radioligand-therapy-165200923.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0320765489.SGD","IE00BJT1NW94.SGD","OS","BK4007","BK4532","BK4578","IE00B2B36J28.USD","NVS","LU0211331839.USD","IE00BFTCPJ56.SGD","BK4585","IE00B4R5TH58.HKD","LU0070302665.USD","IE0009355771.USD","IE00BJJMRZ35.SGD","BK4097","LU0208291251.USD","BK4588","IE0002141913.USD"],"gpt_icon":0},{"id":"2523500843","title":"Novus Holdings Says TRP Withdraws Approval Of Co's Firm Intention Announcement","url":"https://stock-news.laohu8.com/highlight/detail?id=2523500843","media":"T-Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523500843?lang=en_us&edition=fundamental","pubTime":"2025-03-28 23:17","pubTimestamp":1743175046,"startTime":"0","endTime":"0","summary":"Novus Holdings Ltd :Novus Holdings Ltd - Trp Withdraws Approval Of Novus' Firm Intention Announcement.Novus Holdings Ltd - To Appeal Trp Ruling On Urgent Basis.Novus Holdings Ltd - Trp Directs Novus To Publish Revised Firm Intention Announcement Within 20 Days.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.trkd.thomsonreuters.com","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0002141913.USD","IE00B2B36J28.USD","BK4585","BK4588","LU0320765489.SGD","BK4532","LU0070302665.USD","IE0009355771.USD","LU0208291251.USD","IE00BJJMRZ35.SGD","NVS","IE00B4R5TH58.HKD","BK4007","BK4578","IE00BJT1NW94.SGD","IE00BFTCPJ56.SGD","LU0211331839.USD"],"gpt_icon":0},{"id":"2522850130","title":"Here's Why Novartis (NVS) is a Strong Value Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2522850130","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522850130?lang=en_us&edition=fundamental","pubTime":"2025-03-28 21:40","pubTimestamp":1743169212,"startTime":"0","endTime":"0","summary":"For new and old investors, taking full advantage of the stock market and investing with confidence are common goals.While you may have an investing style you rely on, finding great stocks is made easier with the Zacks Style Scores. These are complementary indicators that rate stocks based on value, growth, and/or momentum characteristics.Why Investors Should Pay Attention to This Value Stock. Finding good stocks at good prices, and discovering which companies are trading under their true value, are what value investors like to focus on. So, the Value Style Score takes into account ratios like P/E, PEG, Price/Sales, and Price/Cash Flow to highlight the most attractive and discounted stocks.NVS is a Zacks Rank #3  stock, with a Value Style Score of B and VGM Score of B. Shares are currently trading at a forward P/E of 13.2X for the current fiscal year compared to the Large Cap Pharmaceuticals industry's P/E of 14.1X. Additionally, NVS has a PEG Ratio of 1.8 and a Price/Cash Flow ratio of","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/heres-why-novartis-nvs-strong-134012219.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4588","LU0320765489.SGD","BK4007","BK4585","BK4532","IE00BJT1NW94.SGD","IE0009355771.USD","IE00BFTCPJ56.SGD","IE0002141913.USD","IE00BJJMRZ35.SGD","LU0070302665.USD","LU0211331839.USD","IE00B2B36J28.USD","NVS","LU0208291251.USD","BK4578","IE00B4R5TH58.HKD"],"gpt_icon":0},{"id":"2522582985","title":"Novartis AG Rises Thursday, Outperforms Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2522582985","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522582985?lang=en_us&edition=fundamental","pubTime":"2025-03-28 01:15","pubTimestamp":1743095700,"startTime":"0","endTime":"0","summary":"This article was automatically generated using Dow Jones technology.Shares of Novartis AG  rose 1.0% to CHF98.29 Thursday on what proved to be an overall unfavorable trading session for the stock market, with the Swiss SMI Index  falling 0.7% to 12,867.23.The stock's rise snapped a four-day losing streak.Novartis AG closed CHF4.43 below its 52-week high of CHF102.72, which the company reached on September 2, 2024.Trading volume was 3,115,213, compared to the 50-day average trading volume of 4,119,935.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AG","NVS"],"gpt_icon":0},{"id":"2522062797","title":"Novartis to present new data at AAN, including seven-year disability outcomes and safety analysis of Kesimpta® in people with relapsing multiple sclerosis","url":"https://stock-news.laohu8.com/highlight/detail?id=2522062797","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522062797?lang=en_us&edition=fundamental","pubTime":"2025-03-25 14:15","pubTimestamp":1742883300,"startTime":"0","endTime":"0","summary":"Novartis to present new data at AAN, including seven-year disability outcomes and safety analysis of Kesimpta in people with relapsing multiple sclerosis. Long-term disability and safety data from ALITHIOS open-label extension study on continuous treatment with Kesimpta vs. later switch from teriflunomide in relapsing multiple sclerosis  patients to be presented. Additional presentations highlight the Novartis neuroscience pipeline, including remibrutinib for RMS and iptacopan for generalized myasthenia gravis. Basel, March 25, 2025 – Novartis will present data from studies across its neuroscience portfolio, including seven-year disability outcomes and safety data from the ALITHIOS open-label extension trial of Kesimpta  in people with relapsing multiple sclerosis , at the American Academy of Neurology  2025 Annual Meeting inSan Diego from April 5-9,2025. Additional data on Kesimpta and pipeline assets including remibrutinib and iptacopan will also be highlighted.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/novartis-present-data-aan-including-061500982.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IE0009355771.USD","NVS","BK4532","IE00BJJMRZ35.SGD","LU0320765489.SGD","AAN","BK4585","BK4166","IE00BJT1NW94.SGD","LU0070302665.USD","IE0002141913.USD","BK4578","BK4588","BK4007","PT","LU0208291251.USD","IE00B2B36J28.USD","BK4178","IE00B4R5TH58.HKD","IE00BFTCPJ56.SGD","LU0211331839.USD"],"gpt_icon":0},{"id":"2522708395","title":"Novartis AG Falls Monday, Underperforms Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2522708395","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522708395?lang=en_us&edition=fundamental","pubTime":"2025-03-25 01:15","pubTimestamp":1742836500,"startTime":"0","endTime":"0","summary":"This article was automatically generated using Dow Jones technology.Shares of Novartis AG  dropped 0.7% to CHF98.57 Monday on what proved to be an overall unfavorable trading session for the stock market, with the Swiss SMI Index  falling 0.6% to 13,000.24.This was the stock's second consecutive day of losses.Novartis AG closed CHF4.15 below its 52-week high of CHF102.72, which the company achieved on September 2, 2024.Trading volume was 3,272,988, compared to the 50-day average trading volume of 4,072,328.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AG","NVS"],"gpt_icon":0},{"id":"2521584612","title":"Alnylam Gets FDA Nod for Expanded Use of Amvuttra in Cardiomyopathy","url":"https://stock-news.laohu8.com/highlight/detail?id=2521584612","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521584612?lang=en_us&edition=fundamental","pubTime":"2025-03-22 00:46","pubTimestamp":1742575560,"startTime":"0","endTime":"0","summary":"ALNY’s Amvuttra, an RNAi therapeutic, was previously approved in the United States for treating adult patients with polyneuropathy associated with transthyretin-mediated amyloidosis . It is also marketed in the EU for treating hATTR-PN in adult patients with stage 1 or stage 2 polyneuropathy.The FDA’s latest nod makes Amvuttra the first and only therapeutic approved in the United Statesfor both ATTR-CM and hATTR-PN in adults, marking a significant milestone achievement. ATTR-CM is a severe, rapidly progressing, and life-threatening disease affecting an estimated 150,000 people in the United States and over 300,000 globally. Despite its impact, most cases go undiagnosed and untreated, while many patients receiving standard therapies continue to experience disease progression.The approval of Amvuttra’s supplemental new drug application  for the ATTR-CM indication is based on positiveresults from Alnylam’s pivotal phase III HELIOS-B study of the drug, which met all primary and secondary e","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/alnylam-gets-fda-nod-expanded-164600244.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["ALNY","LU1571399168.USD","BK4568","LU1839511570.USD","IE0009355771.USD","IE0002141913.USD","BK4583","BK4007","BK4548","IE00BJT1NW94.SGD","IE00BZ1G4Q59.USD","LU0289739699.SGD","IE00B19Z3581.USD","LU1585245621.USD","BK4532","IE00BJJMRZ35.SGD","LU2468319806.SGD","LU2087621335.USD","LU2089984988.USD","IE00B4R5TH58.HKD","NVS","DVAX","IE00BFTCPJ56.SGD","LU1066051498.USD","LU0889565916.HKD","LU0208291251.USD","BK4588","LU0320765992.SGD","BK4585","IE00B2B36J28.USD","LU0234570918.USD","BK4550","BK4566","IE00B3T34201.USD","LU0109394709.USD","IE0002270589.USD","IE00BSNM7G36.USD","LU0070302665.USD","LU0058720904.USD","LU1066053197.SGD","GILD","LU0211331839.USD","BK4578","IE00B19Z3B42.SGD","BK4139","IE00B7SZLL34.SGD","LU0320765489.SGD","IE00BKVL7J92.USD","LU1430594728.SGD"],"gpt_icon":0},{"id":"2521498258","title":"Pharma Stock Roundup: PFE's Final Haleon Stake Sale, AZN, SNY M&A Deals","url":"https://stock-news.laohu8.com/highlight/detail?id=2521498258","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521498258?lang=en_us&edition=fundamental","pubTime":"2025-03-22 00:26","pubTimestamp":1742574360,"startTime":"0","endTime":"0","summary":"This week, the FDA approved J&J’s JNJ Tremfya for its second inflammatory bowel disease  condition, Crohn’s disease , and Novartis’ NVS Fabhalta for its third indication, C3 glomerulopathy . Pfizer PFE sold its remaining 7.3% stake in Haleon, thus fully exiting the consumer health company. Sanofi SNY and AstraZeneca AZN announced small acquisition deals.Here's a recap of the week’s most important stories.Haleon was a consumer health joint venture jointly created by Pfizer and GSK in 2019. GSK owned a controlling stake of 68% in the Consumer Healthcare JV . GSK/Pfizer divested the CHC JV to form Haleon in July 2022. GSK, which initially owned a nearly 13% stake in Haleon, sold its entire stake in May 2024. Pfizer originally held a 32% stake in Haleon, which it had started gradually reducing since 2022.FDA Approves NVS’ Fabhalta for Rare Kidney Disease","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/pharma-stock-roundup-pfes-final-162600943.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0795875169.SGD","LU0985481810.HKD","AZN","BK4550","SG9999002232.USD","IE00BLSP4239.USD","LU2505996509.AUD","LU0098860793.USD","SNY","LU0225771236.USD","IE00BJJMRZ35.SGD","LU1829250122.USD","LU2592432038.USD","BK4007","JNJ","LU2129689605.HKD","LU2129689514.USD","LU2462157665.USD","SG9999002224.SGD","LU1221951129.SGD","LU1674673691.USD","LU2236285917.USD","HLN","LU1585245621.USD","LU1778281490.HKD","BK4581","LU0889566641.SGD","LU1057294990.SGD","LU1506573853.SGD","BK4183","BK4532","LU0225284248.USD","SG9999003800.SGD","LU1267930813.SGD","LU0234570918.USD","IE00B19Z3B42.SGD","LU0109394709.USD","LU1221951046.USD","NVS","LU1280957306.USD","LU2430703178.SGD","LU1066051498.USD","IE00BFTCPJ56.SGD","LU0058720904.USD","LU2430703095.HKD","SG9999011175.SGD","LU1732800096.USD","BK4592","LU0320765646.SGD","PFE"],"gpt_icon":1}],"pageSize":20,"totalPage":10,"pageCount":1,"totalSize":200}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NVS\",params:#limit:5,,,undefined,":[{"date":"2025-04-29","symbol":"NVS","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1745913600000,"name":null,"time":"Pre-Market","dateTimestamp":1745899200000,"actualEps":null},{"date":"2025-03-12","symbol":"NVS","amount":3.86954,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-12","defaultRemindTime":1741786200000,"name":"诺华","lastCurrency":null,"lastExecuteDate":null,"recordDate":null,"payableDate":"2025-03-12","currency":"USD","dateTimestamp":1741752000000,"payDate":null},{"market":"US","date":"2025-01-31","symbol":"NVS","fiscalQuarterEnding":"2024/12","expectedEps":1.81,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1738299600000,"reportTimeType":"pre","actualEps":1.98},{"market":"US","date":"2024-10-29","symbol":"NVS","fiscalQuarterEnding":"2024/09","expectedEps":1.94,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1730174400000,"reportTimeType":"pre","actualEps":2.06},{"market":"US","date":"2024-07-18","symbol":"NVS","fiscalQuarterEnding":"2024/06","expectedEps":1.87,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1721275200000,"reportTimeType":"pre","actualEps":1.97}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NVS\",market:\"US\",,,undefined,":[{"executeDate":"2016-02-24","recordDate":"2016-02-26","paymentDate":"2016-04-15","value":2.302755,"currency":"USD"},{"executeDate":"2019-03-04","recordDate":"2019-03-05","paymentDate":"2019-03-13","value":1.861996,"currency":"USD"},{"executeDate":"2020-03-03","recordDate":"2020-03-04","paymentDate":"2020-03-12","value":1.9776197,"currency":"USD"},{"executeDate":"2021-03-04","recordDate":"2021-03-05","paymentDate":"2021-03-15","value":2.1959459,"currency":"USD"},{"executeDate":"2022-03-08","recordDate":"2022-03-09","paymentDate":"2022-03-17","value":3.3574492,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"NVS\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":0.1111,"hold":0.6667,"sell":0.2222,"strongSell":0,"meanLabel":"HOLD","meanPercent":0.6667,"analysts":9,"updateTime":1741147200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/NVS\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"NVS","date":"2025-04-04","current":17.039027,"percent":0.446429,"low":7.087581,"twenty":9.17305,"median":18.728326,"eighty":26.564795,"high":33.848621,"avg":18.939573,"sd":7.686427,"marketCap":203463019508.1},"quantilePoints":[{"date":"2020-04-09","current":16.414005,"twenty":14.975569,"median":17.777929,"eighty":28.151237,"marketCap":192569103462.06},{"date":"2020-04-17","current":17.174596,"twenty":14.976589,"median":17.760725,"eighty":28.130706,"marketCap":201492366063.26},{"date":"2020-04-24","current":17.025776,"twenty":14.99949,"median":17.673233,"eighty":28.122595,"marketCap":199746401716.16},{"date":"2020-05-01","current":16.167971,"twenty":15.021686,"median":17.638302,"eighty":28.078196,"marketCap":196311510911.14},{"date":"2020-05-08","current":16.06719,"twenty":15.022068,"median":17.611494,"eighty":28.067058,"marketCap":195087824511.38},{"date":"2020-05-15","current":15.133928,"twenty":15.029105,"median":17.577522,"eighty":28.059696,"marketCap":183756150779.48},{"date":"2020-05-22","current":15.343364,"twenty":15.030337,"median":17.539345,"eighty":28.029058,"marketCap":186299125645.41},{"date":"2020-05-29","current":15.670723,"twenty":15.048567,"median":17.506592,"eighty":28.022419,"marketCap":190273917101.96},{"date":"2020-06-05","current":15.653235,"twenty":15.05741,"median":17.491087,"eighty":28.017268,"marketCap":190061581744.23},{"date":"2020-06-12","current":15.30119,"twenty":15.060887,"median":17.476205,"eighty":27.997804,"marketCap":185787049141.61},{"date":"2020-06-19","current":16.556853,"twenty":15.077447,"median":17.466898,"eighty":27.987006,"marketCap":201033316893.8},{"date":"2020-06-26","current":15.916169,"twenty":15.084669,"median":17.460565,"eighty":27.982482,"marketCap":193254122511.55},{"date":"2020-07-02","current":15.939875,"twenty":15.096906,"median":17.438742,"eighty":27.965467,"marketCap":193541959173.38},{"date":"2020-07-10","current":15.827476,"twenty":15.105726,"median":17.415673,"eighty":27.932834,"marketCap":192177214934.9},{"date":"2020-07-17","current":15.909995,"twenty":15.108152,"median":17.408633,"eighty":27.905383,"marketCap":193179148808.17},{"date":"2020-07-24","current":25.866578,"twenty":15.110436,"median":17.413902,"eighty":27.890944,"marketCap":186498028239.8},{"date":"2020-07-31","current":25.307939,"twenty":15.11173,"median":17.428065,"eighty":27.882963,"marketCap":182470241873.48},{"date":"2020-08-07","current":25.275976,"twenty":15.12518,"median":17.460369,"eighty":27.855072,"marketCap":182239790737.98},{"date":"2020-08-14","current":25.963677,"twenty":15.136152,"median":17.46483,"eighty":27.822479,"marketCap":187198114700.06},{"date":"2020-08-21","current":26.31296,"twenty":15.145226,"median":17.469399,"eighty":27.751331,"marketCap":189716446657.38},{"date":"2020-08-28","current":26.432206,"twenty":15.157076,"median":17.490797,"eighty":27.687759,"marketCap":190576209962.38},{"date":"2020-09-04","current":26.289955,"twenty":15.163392,"median":17.505765,"eighty":27.512066,"marketCap":189550574045.52},{"date":"2020-09-11","current":27.499584,"twenty":15.165426,"median":17.535576,"eighty":27.461844,"marketCap":198272000195.83},{"date":"2020-09-18","current":27.874868,"twenty":15.167813,"median":17.566173,"eighty":27.688711,"marketCap":200977799366.41},{"date":"2020-09-25","current":26.408027,"twenty":15.174934,"median":17.592165,"eighty":27.663643,"marketCap":190401873862.84},{"date":"2020-10-02","current":26.708229,"twenty":15.183274,"median":17.637235,"eighty":27.633307,"marketCap":192566335706.05},{"date":"2020-10-09","current":27.059181,"twenty":15.18461,"median":17.670441,"eighty":27.56422,"marketCap":195096692723.52},{"date":"2020-10-16","current":26.362521,"twenty":15.18744,"median":17.737178,"eighty":27.461844,"marketCap":190073773914.09},{"date":"2020-10-23","current":25.797382,"twenty":15.190989,"median":17.775785,"eighty":27.402807,"marketCap":185999119226.86},{"date":"2020-10-30","current":24.988388,"twenty":15.193883,"median":17.792728,"eighty":27.388696,"marketCap":177492523698.86},{"date":"2020-11-06","current":27.216027,"twenty":15.199589,"median":17.829937,"eighty":27.357723,"marketCap":193315439822.18},{"date":"2020-11-13","current":27.485895,"twenty":15.20954,"median":17.865475,"eighty":27.402807,"marketCap":195232311745.39},{"date":"2020-11-20","current":27.977491,"twenty":15.21419,"median":17.948734,"eighty":27.570986,"marketCap":198724117569.53},{"date":"2020-11-27","current":28.696184,"twenty":15.217792,"median":17.957315,"eighty":27.667977,"marketCap":203828990967.78},{"date":"2020-12-04","current":29.177337,"twenty":15.226366,"median":17.977434,"eighty":27.722608,"marketCap":207246629519.95},{"date":"2020-12-11","current":29.329405,"twenty":15.231613,"median":17.986357,"eighty":27.833026,"marketCap":208326758462.39},{"date":"2020-12-18","current":29.122537,"twenty":15.23366,"median":17.997105,"eighty":27.894825,"marketCap":206857381598.42},{"date":"2020-12-24","current":28.223441,"twenty":15.238838,"median":18.012439,"eighty":27.939463,"marketCap":200471097283.05},{"date":"2020-12-31","current":30.275456,"twenty":15.242355,"median":18.038048,"eighty":27.982482,"marketCap":215046563030.23},{"date":"2021-01-08","current":30.050051,"twenty":15.243996,"median":18.077533,"eighty":28.022419,"marketCap":213445512050.29},{"date":"2021-01-15","current":30.69708,"twenty":15.252301,"median":18.087632,"eighty":28.087076,"marketCap":218041359312.66},{"date":"2021-01-22","current":31.075017,"twenty":15.257047,"median":18.107937,"eighty":28.154132,"marketCap":220725844580.34},{"date":"2021-01-29","current":25.302982,"twenty":15.267282,"median":18.143206,"eighty":28.154132,"marketCap":204245667129.31},{"date":"2021-02-05","current":25.307678,"twenty":15.27441,"median":18.16572,"eighty":28.138918,"marketCap":204283575482.98},{"date":"2021-02-12","current":25.723524,"twenty":15.27628,"median":18.200034,"eighty":28.125839,"marketCap":207640289409.26},{"date":"2021-02-19","current":24.769133,"twenty":15.278711,"median":18.210204,"eighty":28.104835,"marketCap":199936445479.85},{"date":"2021-02-26","current":24.064713,"twenty":15.284399,"median":18.226261,"eighty":28.073741,"marketCap":194250364295.15},{"date":"2021-03-05","current":23.084461,"twenty":15.288901,"median":18.233974,"eighty":28.064113,"marketCap":186337768880.54},{"date":"2021-03-12","current":23.435071,"twenty":15.291775,"median":18.240532,"eighty":28.047441,"marketCap":189167893568.67},{"date":"2021-03-19","current":24.013766,"twenty":15.297229,"median":18.250058,"eighty":28.025738,"marketCap":193839113911.88},{"date":"2021-03-26","current":24.361283,"twenty":15.300148,"median":18.274818,"eighty":28.019013,"marketCap":196644272477.68},{"date":"2021-04-01","current":24.108173,"twenty":15.308128,"median":18.305737,"eighty":28.011747,"marketCap":194601172227.48},{"date":"2021-04-09","current":24.426603,"twenty":15.336914,"median":18.352215,"eighty":27.991619,"marketCap":197171541159.64},{"date":"2021-04-16","current":24.594705,"twenty":15.34149,"median":18.380221,"eighty":27.984722,"marketCap":198528460498.63},{"date":"2021-04-23","current":24.625032,"twenty":15.343269,"median":18.411754,"eighty":27.980886,"marketCap":198773259403.94},{"date":"2021-04-30","current":24.094521,"twenty":15.343969,"median":18.498755,"eighty":27.972917,"marketCap":191671912423.89},{"date":"2021-05-07","current":24.8617,"twenty":15.348946,"median":18.532645,"eighty":27.95159,"marketCap":197774820664.93},{"date":"2021-05-14","current":25.153836,"twenty":15.363808,"median":18.565357,"eighty":27.935232,"marketCap":200098770040.64},{"date":"2021-05-21","current":24.924084,"twenty":15.38257,"median":18.594345,"eighty":27.9145,"marketCap":198271089998.22},{"date":"2021-05-28","current":24.965271,"twenty":15.386047,"median":18.628586,"eighty":27.898767,"marketCap":198598732228.7},{"date":"2021-06-04","current":25.428717,"twenty":15.396316,"median":18.694716,"eighty":27.896766,"marketCap":202285445340.91},{"date":"2021-06-11","current":26.151461,"twenty":15.42367,"median":18.776218,"eighty":27.887062,"marketCap":208034875736.78},{"date":"2021-06-18","current":26.227743,"twenty":15.426334,"median":18.837947,"eighty":27.88023,"marketCap":208641694627},{"date":"2021-06-25","current":26.052263,"twenty":15.431826,"median":18.905909,"eighty":27.874868,"marketCap":207245745997.25},{"date":"2021-07-02","current":25.85105,"twenty":15.440199,"median":18.948871,"eighty":27.8383,"marketCap":205645103265.31},{"date":"2021-07-09","current":26.180675,"twenty":15.452123,"median":19.994076,"eighty":27.817206,"marketCap":208267270363.9},{"date":"2021-07-16","current":25.922565,"twenty":15.45839,"median":21.297567,"eighty":27.783193,"marketCap":206214009499.37},{"date":"2021-07-23","current":22.872298,"twenty":15.460519,"median":21.410694,"eighty":27.739049,"marketCap":205484727078.08},{"date":"2021-07-30","current":23.045934,"twenty":15.461717,"median":21.438592,"eighty":27.726383,"marketCap":207044671996.42},{"date":"2021-08-06","current":22.739522,"twenty":15.46988,"median":21.573064,"eighty":27.713849,"marketCap":204291865840.83},{"date":"2021-08-13","current":23.359628,"twenty":15.503564,"median":21.698856,"eighty":27.702531,"marketCap":209862894026.22},{"date":"2021-08-20","current":23.181179,"twenty":15.520325,"median":21.783237,"eighty":27.699801,"marketCap":208259712288.12},{"date":"2021-08-27","current":22.984623,"twenty":15.530062,"median":21.84709,"eighty":27.677778,"marketCap":206493850543.31},{"date":"2021-09-03","current":22.718035,"twenty":15.538322,"median":21.869287,"eighty":27.654974,"marketCap":204098826165.09},{"date":"2021-09-10","current":21.345254,"twenty":15.550583,"median":21.869287,"eighty":27.626214,"marketCap":191765758544.03},{"date":"2021-09-17","current":20.712438,"twenty":15.559277,"median":21.84709,"eighty":27.608358,"marketCap":186080540393.19},{"date":"2021-09-24","current":20.705728,"twenty":15.579952,"median":21.783237,"eighty":27.552824,"marketCap":186020268740.41},{"date":"2021-10-01","current":20.345304,"twenty":15.600577,"median":21.698856,"eighty":27.50635,"marketCap":182782211476.64},{"date":"2021-10-08","current":20.562654,"twenty":15.609566,"median":21.649563,"eighty":27.491371,"marketCap":184734878306.34},{"date":"2021-10-15","current":20.740241,"twenty":15.618942,"median":21.463043,"eighty":27.437499,"marketCap":186330331047.78},{"date":"2021-10-22","current":21.058392,"twenty":15.627389,"median":21.428036,"eighty":27.401594,"marketCap":189188586652.7},{"date":"2021-10-29","current":18.817338,"twenty":15.635032,"median":21.347439,"eighty":27.383461,"marketCap":184541630310.6},{"date":"2021-11-05","current":19.018891,"twenty":15.647289,"median":21.317885,"eighty":27.350089,"marketCap":186518259165.92},{"date":"2021-11-12","current":18.891167,"twenty":15.654532,"median":21.179825,"eighty":27.307652,"marketCap":185265673842.84},{"date":"2021-11-19","current":18.728326,"twenty":15.663321,"median":21.048046,"eighty":27.254761,"marketCap":183668699163.22},{"date":"2021-11-26","current":18.466622,"twenty":15.669452,"median":21.012114,"eighty":27.229251,"marketCap":181102155276.87},{"date":"2021-12-03","current":18.258168,"twenty":15.672299,"median":20.862779,"eighty":27.221869,"marketCap":179057860494.36},{"date":"2021-12-10","current":18.5005,"twenty":15.679373,"median":20.754728,"eighty":27.20819,"marketCap":181434401677.24},{"date":"2021-12-17","current":19.741364,"twenty":15.68813,"median":20.712438,"eighty":27.181553,"marketCap":193603556286.26},{"date":"2021-12-23","current":19.848527,"twenty":15.692775,"median":20.705728,"eighty":27.155854,"marketCap":194654498880},{"date":"2021-12-31","current":20.088424,"twenty":15.701331,"median":20.618532,"eighty":27.138533,"marketCap":197007170988.69},{"date":"2022-01-07","current":20.258584,"twenty":15.705623,"median":20.60602,"eighty":27.121927,"marketCap":198675935418.57},{"date":"2022-01-14","current":20.570686,"twenty":15.723796,"median":20.589637,"eighty":27.105451,"marketCap":201736710825.32},{"date":"2022-01-21","current":19.970714,"twenty":15.736051,"median":20.56667,"eighty":27.061491,"marketCap":195852789238.19},{"date":"2022-01-28","current":19.465055,"twenty":15.746378,"median":20.545058,"eighty":27.059181,"marketCap":190893794335.26},{"date":"2022-02-04","current":8.029227,"twenty":15.720732,"median":20.461012,"eighty":27.056778,"marketCap":192870073011.45},{"date":"2022-02-11","current":8.018981,"twenty":15.689822,"median":20.425342,"eighty":27.053184,"marketCap":192623938080.47},{"date":"2022-02-18","current":8.065272,"twenty":15.689822,"median":20.425342,"eighty":27.053184,"marketCap":193735890248.88},{"date":"2022-02-25","current":8.114918,"twenty":15.689822,"median":20.425342,"eighty":27.053184,"marketCap":194928434328.79},{"date":"2022-03-04","current":7.836403,"twenty":15.689822,"median":20.425342,"eighty":27.053184,"marketCap":188238254501.41},{"date":"2022-03-11","current":7.721781,"twenty":15.689822,"median":20.425342,"eighty":27.053184,"marketCap":185484909723.96},{"date":"2022-03-18","current":8.057829,"twenty":15.689822,"median":20.425342,"eighty":27.053184,"marketCap":193557099512.19},{"date":"2022-03-25","current":8.071441,"twenty":15.689822,"median":20.425342,"eighty":27.053184,"marketCap":193884091322.71},{"date":"2022-04-01","current":8.094547,"twenty":15.689822,"median":20.425342,"eighty":27.053184,"marketCap":194439100004.32},{"date":"2022-04-08","current":8.638654,"twenty":15.689822,"median":20.425342,"eighty":27.053184,"marketCap":207509117437.99},{"date":"2022-04-14","current":8.640519,"twenty":15.689822,"median":20.425342,"eighty":27.053184,"marketCap":207553893767.01},{"date":"2022-04-22","current":8.353937,"twenty":15.689822,"median":20.425342,"eighty":27.053184,"marketCap":200669919872.67},{"date":"2022-04-29","current":8.131471,"twenty":15.665963,"median":20.330649,"eighty":27.053184,"marketCap":196651481774.28},{"date":"2022-05-06","current":7.881676,"twenty":15.621187,"median":20.256294,"eighty":27.03613,"marketCap":190610438695.01},{"date":"2022-05-13","current":7.895122,"twenty":15.554139,"median":20.050708,"eighty":26.799658,"marketCap":190935630327.25},{"date":"2022-05-20","current":7.981506,"twenty":15.46988,"median":19.939865,"eighty":26.712067,"marketCap":193024747095},{"date":"2022-05-27","current":8.181613,"twenty":15.438524,"median":19.636273,"eighty":26.626409,"marketCap":197864120623.02},{"date":"2022-06-03","current":8.00738,"twenty":15.393749,"median":19.478952,"eighty":26.562818,"marketCap":193650479646.81},{"date":"2022-06-10","current":7.624373,"twenty":15.34334,"median":19.163283,"eighty":26.481397,"marketCap":184387844631.82},{"date":"2022-06-17","current":7.304054,"twenty":15.298712,"median":19.077284,"eighty":26.418719,"marketCap":176641242394.35},{"date":"2022-06-24","current":7.582309,"twenty":15.27964,"median":18.986834,"eighty":26.364561,"marketCap":183370574720.06},{"date":"2022-07-01","current":7.493877,"twenty":15.250273,"median":18.900841,"eighty":26.314464,"marketCap":181231913048.72},{"date":"2022-07-08","current":7.606086,"twenty":15.23199,"median":18.869162,"eighty":26.291679,"marketCap":183945576164.31},{"date":"2022-07-15","current":7.58856,"twenty":15.202136,"median":18.806098,"eighty":26.232109,"marketCap":183521723409.93},{"date":"2022-07-22","current":8.19561,"twenty":15.18337,"median":18.71718,"eighty":26.166494,"marketCap":188351517085.2},{"date":"2022-07-29","current":8.158045,"twenty":15.157076,"median":18.647438,"eighty":26.132159,"marketCap":187488206041.27},{"date":"2022-08-05","current":8.078369,"twenty":15.110436,"median":18.578085,"eighty":26.065871,"marketCap":185657067852.22},{"date":"2022-08-12","current":8.066066,"twenty":15.073457,"median":18.515669,"eighty":25.940642,"marketCap":185374335649.61},{"date":"2022-08-19","current":8.123102,"twenty":15.02629,"median":18.4837,"eighty":25.886111,"marketCap":186685117272.05},{"date":"2022-08-26","current":7.921009,"twenty":14.971809,"median":18.427077,"eighty":25.833627,"marketCap":182040613492.93},{"date":"2022-09-02","current":7.69931,"twenty":14.889831,"median":18.390521,"eighty":25.781076,"marketCap":176945538997.44},{"date":"2022-09-09","current":7.839444,"twenty":14.847478,"median":18.352215,"eighty":25.737059,"marketCap":180166100535.63},{"date":"2022-09-16","current":7.639838,"twenty":14.800639,"median":18.279395,"eighty":25.69413,"marketCap":175578771828.6},{"date":"2022-09-23","current":7.200687,"twenty":14.715721,"median":18.250058,"eighty":25.606633,"marketCap":165486184420.18},{"date":"2022-09-30","current":7.309364,"twenty":14.666961,"median":18.233974,"eighty":25.536644,"marketCap":167983801405.08},{"date":"2022-10-07","current":7.233971,"twenty":14.612953,"median":18.210204,"eighty":25.43593,"marketCap":166251109031.05},{"date":"2022-10-14","current":7.191933,"twenty":14.497159,"median":18.168977,"eighty":25.32345,"marketCap":165284995916.46},{"date":"2022-10-21","current":7.25195,"twenty":14.457826,"median":18.113862,"eighty":25.286138,"marketCap":166664300685.15},{"date":"2022-10-28","current":7.929368,"twenty":14.315805,"median":18.077533,"eighty":25.233079,"marketCap":172836429210.02},{"date":"2022-11-04","current":8.027551,"twenty":14.283277,"median":18.007982,"eighty":25.152421,"marketCap":174976531233.09},{"date":"2022-11-11","current":8.242312,"twenty":14.244857,"median":17.98094,"eighty":25.087357,"marketCap":179657664851.58},{"date":"2022-11-18","current":8.457603,"twenty":14.191615,"median":17.955359,"eighty":24.985599,"marketCap":184350366168.97},{"date":"2022-11-25","current":8.657467,"twenty":14.143838,"median":17.845766,"eighty":24.944555,"marketCap":188706817286.19},{"date":"2022-12-02","current":8.838391,"twenty":14.078613,"median":17.783631,"eighty":24.901055,"marketCap":192650402692.03},{"date":"2022-12-09","current":9.046654,"twenty":14.034813,"median":17.713631,"eighty":24.828177,"marketCap":197189931786.84},{"date":"2022-12-16","current":8.906442,"twenty":14.013992,"median":17.636168,"eighty":24.769512,"marketCap":194133722263.41},{"date":"2022-12-23","current":8.960744,"twenty":13.971607,"median":17.554825,"eighty":24.727245,"marketCap":195317323645.23},{"date":"2022-12-30","current":8.920871,"twenty":13.914951,"median":17.505765,"eighty":24.703969,"marketCap":194448241062.22},{"date":"2023-01-06","current":9.093242,"twenty":13.856188,"median":17.48301,"eighty":24.625204,"marketCap":198205406557.8},{"date":"2023-01-13","current":9.002411,"twenty":13.821776,"median":17.460761,"eighty":24.583673,"marketCap":196225557627.91},{"date":"2023-01-20","current":9.051584,"twenty":13.776842,"median":17.424808,"eighty":24.543498,"marketCap":197297374275.26},{"date":"2023-01-27","current":8.847624,"twenty":13.673815,"median":17.405208,"eighty":24.464769,"marketCap":192851676130.76},{"date":"2023-02-03","current":26.243556,"twenty":13.627087,"median":17.400788,"eighty":24.459661,"marketCap":182523930790.97},{"date":"2023-02-10","current":26.294961,"twenty":13.627087,"median":17.400788,"eighty":24.459661,"marketCap":182881448586.32},{"date":"2023-02-17","current":26.374513,"twenty":13.627087,"median":17.400788,"eighty":24.459661,"marketCap":183434736554.71},{"date":"2023-02-24","current":26.177477,"twenty":13.627087,"median":17.400788,"eighty":24.459661,"marketCap":182064354704.07},{"date":"2023-03-03","current":25.765519,"twenty":13.627087,"median":17.400788,"eighty":24.459661,"marketCap":179199184580.8},{"date":"2023-03-10","current":24.700467,"twenty":13.627087,"median":17.400788,"eighty":24.459661,"marketCap":171791749395.01},{"date":"2023-03-17","current":26.915798,"twenty":13.627087,"median":17.400788,"eighty":24.459661,"marketCap":187199370174.87},{"date":"2023-03-24","current":27.246033,"twenty":13.627087,"median":17.400788,"eighty":24.543498,"marketCap":189496154839.06},{"date":"2023-03-31","current":30.054098,"twenty":13.630004,"median":17.402998,"eighty":24.587255,"marketCap":209026250254.21},{"date":"2023-04-06","current":31.533443,"twenty":13.630004,"median":17.402998,"eighty":24.625118,"marketCap":219315097125.45},{"date":"2023-04-14","current":32.274976,"twenty":13.627087,"median":17.400788,"eighty":24.706379,"marketCap":224472453860.2},{"date":"2023-04-21","current":32.553317,"twenty":13.627087,"median":17.400788,"eighty":24.770643,"marketCap":226408322073.89},{"date":"2023-04-28","current":30.395591,"twenty":13.627087,"median":17.400788,"eighty":24.870311,"marketCap":213559421622.35},{"date":"2023-05-05","current":31.378954,"twenty":13.624171,"median":17.400508,"eighty":24.92381,"marketCap":220468531572.95},{"date":"2023-05-12","current":30.870482,"twenty":13.624171,"median":17.400508,"eighty":24.976352,"marketCap":216896002905.77},{"date":"2023-05-19","current":29.854888,"twenty":13.624171,"median":17.400508,"eighty":25.035144,"marketCap":209760441249.27},{"date":"2023-05-26","current":29.284412,"twenty":13.624171,"median":17.400508,"eighty":25.151225,"marketCap":205752279633.25},{"date":"2023-06-02","current":29.357697,"twenty":13.624171,"median":17.400508,"eighty":25.224214,"marketCap":206267176913.22},{"date":"2023-06-09","current":29.886389,"twenty":13.624171,"median":17.400508,"eighty":25.298929,"marketCap":209981771535.32},{"date":"2023-06-16","current":30.321305,"twenty":13.624171,"median":17.400508,"eighty":25.414052,"marketCap":213037486310.78},{"date":"2023-06-23","current":30.190139,"twenty":13.621254,"median":17.400228,"eighty":25.482171,"marketCap":212115917863.59},{"date":"2023-06-30","current":29.926736,"twenty":13.621254,"median":17.400228,"eighty":25.530882,"marketCap":210265246516.29},{"date":"2023-07-07","current":28.234527,"twenty":13.621254,"median":17.400228,"eighty":25.631737,"marketCap":198375788384.16},{"date":"2023-07-14","current":29.505671,"twenty":13.621254,"median":17.400228,"eighty":25.721137,"marketCap":207306851165.12},{"date":"2023-07-21","current":28.497251,"twenty":13.702614,"median":17.40584,"eighty":25.765158,"marketCap":217946975867.36},{"date":"2023-07-28","current":28.10544,"twenty":13.702614,"median":17.431322,"eighty":25.810163,"marketCap":214950408672.37},{"date":"2023-08-04","current":27.560871,"twenty":13.702614,"median":17.466898,"eighty":25.855767,"marketCap":210785535427.99},{"date":"2023-08-11","current":28.108004,"twenty":13.702614,"median":17.491087,"eighty":25.920889,"marketCap":214970019886.42},{"date":"2023-08-18","current":27.500668,"twenty":13.716822,"median":17.543114,"eighty":25.999939,"marketCap":210325106917.85},{"date":"2023-08-25","current":27.490856,"twenty":13.716822,"median":17.630823,"eighty":26.112124,"marketCap":210250065949.08},{"date":"2023-09-01","current":27.33691,"twenty":13.716822,"median":17.676024,"eighty":26.137251,"marketCap":209072687172.76},{"date":"2023-09-08","current":26.684355,"twenty":13.831992,"median":17.775785,"eighty":26.164037,"marketCap":204081948408.26},{"date":"2023-09-15","current":27.8918,"twenty":13.863753,"median":17.829937,"eighty":26.195299,"marketCap":213316484771.89},{"date":"2023-09-22","current":27.529162,"twenty":13.863753,"median":17.948734,"eighty":26.256036,"marketCap":210543032637.27},{"date":"2023-09-29","current":27.704599,"twenty":13.863753,"median":17.977965,"eighty":26.294822,"marketCap":211884773857.62},{"date":"2023-10-06","current":26.136777,"twenty":13.863753,"median":17.998187,"eighty":26.307358,"marketCap":199894070259.72},{"date":"2023-10-13","current":26.099935,"twenty":13.931808,"median":18.076116,"eighty":26.318536,"marketCap":199612304286.36},{"date":"2023-10-20","current":25.606741,"twenty":13.931808,"median":18.102011,"eighty":26.318536,"marketCap":195840357582.32},{"date":"2023-10-27","current":24.415836,"twenty":13.914417,"median":18.144394,"eighty":26.326723,"marketCap":191322491088.71},{"date":"2023-11-03","current":24.121849,"twenty":13.914417,"median":18.186711,"eighty":26.326723,"marketCap":189018809684.75},{"date":"2023-11-10","current":24.455041,"twenty":13.914417,"median":18.226261,"eighty":26.326723,"marketCap":191629701060.59},{"date":"2023-11-17","current":24.852995,"twenty":13.914417,"median":18.240532,"eighty":26.326723,"marketCap":194748066897.24},{"date":"2023-11-24","current":25.763747,"twenty":13.914417,"median":18.264257,"eighty":26.326723,"marketCap":201884721514.42},{"date":"2023-12-01","current":25.681448,"twenty":13.914417,"median":18.308684,"eighty":26.326723,"marketCap":201239827121.68},{"date":"2023-12-08","current":25.351528,"twenty":13.918256,"median":18.360699,"eighty":26.322856,"marketCap":198654572969.12},{"date":"2023-12-15","current":25.72582,"twenty":13.918256,"median":18.394754,"eighty":26.322856,"marketCap":201587524553.81},{"date":"2023-12-22","current":25.978676,"twenty":13.918256,"median":18.447118,"eighty":26.322856,"marketCap":203568905697.84},{"date":"2023-12-29","current":26.529514,"twenty":13.914417,"median":18.483927,"eighty":26.348002,"marketCap":207885278188.64},{"date":"2024-01-05","current":27.901829,"twenty":13.910577,"median":18.51381,"eighty":26.370883,"marketCap":218638738608.88},{"date":"2024-01-12","current":28.036514,"twenty":13.910577,"median":18.571472,"eighty":26.422243,"marketCap":219694129152.93},{"date":"2024-01-19","current":28.352927,"twenty":13.906738,"median":18.628586,"eighty":26.470944,"marketCap":222173534575.94},{"date":"2024-01-26","current":27.949174,"twenty":13.910577,"median":18.684776,"eighty":26.521392,"marketCap":219009721879.32},{"date":"2024-02-02","current":14.397684,"twenty":13.910577,"median":18.71718,"eighty":26.537684,"marketCap":213805607321.99},{"date":"2024-02-09","current":13.900537,"twenty":13.868427,"median":18.71718,"eighty":26.537684,"marketCap":206422982529.79},{"date":"2024-02-16","current":13.813113,"twenty":13.687988,"median":18.71718,"eighty":26.537684,"marketCap":205124721398.18},{"date":"2024-02-23","current":14.305017,"twenty":13.687988,"median":18.71718,"eighty":26.537684,"marketCap":212429491580.85},{"date":"2024-03-01","current":14.052638,"twenty":13.704706,"median":18.708576,"eighty":26.536229,"marketCap":208681673875.32},{"date":"2024-03-08","current":13.812509,"twenty":13.704706,"median":18.708576,"eighty":26.536229,"marketCap":205115751567.13},{"date":"2024-03-15","current":13.350493,"twenty":13.599085,"median":18.708576,"eighty":26.536229,"marketCap":198254813990.44},{"date":"2024-03-22","current":14.193287,"twenty":13.599085,"median":18.708576,"eighty":26.536229,"marketCap":210770303493.35},{"date":"2024-03-28","current":14.305417,"twenty":13.599085,"median":18.708576,"eighty":26.536229,"marketCap":212435439752.63},{"date":"2024-04-05","current":14.023817,"twenty":13.576499,"median":18.71718,"eighty":26.537684,"marketCap":208253683585.27},{"date":"2024-04-12","current":13.933033,"twenty":13.576499,"median":18.71718,"eighty":26.537684,"marketCap":206905536915.4},{"date":"2024-04-19","current":13.841097,"twenty":13.576499,"median":18.71718,"eighty":26.537684,"marketCap":205540289930.65},{"date":"2024-04-26","current":13.116641,"twenty":13.098986,"median":18.708576,"eighty":26.536229,"marketCap":199963177263.62},{"date":"2024-05-03","current":12.901312,"twenty":12.986611,"median":18.708576,"eighty":26.536229,"marketCap":196680491183.63},{"date":"2024-05-10","current":13.62556,"twenty":12.986611,"median":18.708576,"eighty":26.536229,"marketCap":207721668262.32},{"date":"2024-05-17","current":13.811142,"twenty":12.986611,"median":18.708576,"eighty":26.536229,"marketCap":210550870720.47},{"date":"2024-05-24","current":13.427426,"twenty":12.986611,"median":18.708576,"eighty":26.536229,"marketCap":204701108813.04},{"date":"2024-05-31","current":13.797418,"twenty":12.986611,"median":18.708576,"eighty":26.536229,"marketCap":210341631436.51},{"date":"2024-06-07","current":14.246068,"twenty":12.986611,"median":18.708576,"eighty":26.536229,"marketCap":217181308721.48},{"date":"2024-06-14","current":14.220001,"twenty":12.986611,"median":18.708576,"eighty":26.536229,"marketCap":216783909228.96},{"date":"2024-06-21","current":14.123248,"twenty":12.9792,"median":18.71718,"eighty":26.537684,"marketCap":215308906730.59},{"date":"2024-06-28","current":14.334626,"twenty":12.939152,"median":18.738531,"eighty":26.54537,"marketCap":218531380215.61},{"date":"2024-07-05","current":14.368048,"twenty":12.939152,"median":18.738531,"eighty":26.54537,"marketCap":219040892779.52},{"date":"2024-07-12","current":14.979512,"twenty":12.939152,"median":18.738531,"eighty":26.54537,"marketCap":228362653471.36},{"date":"2024-07-15","current":14.823193,"twenty":12.939152,"median":18.738531,"eighty":26.54537,"marketCap":225979585099.3},{"date":"2024-08-02","current":13.829686,"twenty":9.174052,"median":18.796476,"eighty":26.561516,"marketCap":223695182982.23},{"date":"2024-08-09","current":13.947897,"twenty":9.174052,"median":18.796476,"eighty":26.561516,"marketCap":225607243407.28},{"date":"2024-08-16","current":14.29468,"twenty":9.174052,"median":18.796476,"eighty":26.561516,"marketCap":231216434977.84},{"date":"2024-08-23","current":14.748882,"twenty":9.174052,"median":18.796476,"eighty":26.561516,"marketCap":238563170201.28},{"date":"2024-08-30","current":15.071422,"twenty":9.174052,"median":18.796476,"eighty":26.561516,"marketCap":243780244488.86},{"date":"2024-09-06","current":14.566348,"twenty":9.174052,"median":18.796476,"eighty":26.561516,"marketCap":235610682264},{"date":"2024-09-13","current":14.392965,"twenty":9.174052,"median":18.796476,"eighty":26.561516,"marketCap":232806208493.04},{"date":"2024-09-20","current":14.62573,"twenty":9.174052,"median":18.796476,"eighty":26.561516,"marketCap":236571180766.96},{"date":"2024-09-27","current":14.474714,"twenty":9.174052,"median":18.796476,"eighty":26.561516,"marketCap":234128501124.19},{"date":"2024-10-04","current":14.328493,"twenty":9.174052,"median":18.796476,"eighty":26.561516,"marketCap":231763377879.44},{"date":"2024-10-11","current":14.53281,"twenty":9.174052,"median":18.796476,"eighty":26.561516,"marketCap":235068192144.32},{"date":"2024-10-18","current":14.616396,"twenty":9.174052,"median":18.796476,"eighty":26.561516,"marketCap":236420201553.07},{"date":"2024-10-25","current":14.249607,"twenty":9.174052,"median":18.796476,"eighty":26.561516,"marketCap":230487389403.66},{"date":"2024-10-31","current":12.316052,"twenty":9.174052,"median":18.796476,"eighty":26.561516,"marketCap":216799455601.16},{"date":"2024-11-08","current":12.084082,"twenty":9.173718,"median":18.806098,"eighty":26.562609,"marketCap":212716082431.8},{"date":"2024-11-15","current":11.7431,"twenty":9.173718,"median":18.806098,"eighty":26.562609,"marketCap":206713778876.88},{"date":"2024-11-22","current":12.008212,"twenty":9.173718,"median":18.806098,"eighty":26.562609,"marketCap":211380543419.03},{"date":"2024-11-29","current":11.989078,"twenty":9.173718,"median":18.806098,"eighty":26.562609,"marketCap":211043738444.04},{"date":"2024-12-06","current":11.601044,"twenty":9.173718,"median":18.806098,"eighty":26.562609,"marketCap":204213183580.32},{"date":"2024-12-13","current":11.217052,"twenty":9.173718,"median":18.806098,"eighty":26.562609,"marketCap":197453767709},{"date":"2024-12-20","current":10.977297,"twenty":9.173718,"median":18.806098,"eighty":26.562609,"marketCap":193233357029.33},{"date":"2024-12-27","current":11.209016,"twenty":9.173718,"median":18.806098,"eighty":26.562609,"marketCap":197312315222.73},{"date":"2025-01-03","current":11.085825,"twenty":9.173718,"median":18.806098,"eighty":26.562609,"marketCap":195143766953.58},{"date":"2025-01-10","current":11.339502,"twenty":9.173384,"median":18.806415,"eighty":26.563702,"marketCap":199609258842.55},{"date":"2025-01-17","current":11.132461,"twenty":9.173384,"median":18.806415,"eighty":26.563702,"marketCap":195964707489.63},{"date":"2025-01-24","current":11.289573,"twenty":9.173384,"median":18.806415,"eighty":26.563702,"marketCap":198730349797.09},{"date":"2025-01-31","current":11.960588,"twenty":9.173384,"median":18.806415,"eighty":26.563702,"marketCap":210542226015.58},{"date":"2025-02-07","current":17.70064,"twenty":9.173384,"median":18.806415,"eighty":26.563702,"marketCap":211363341050.81},{"date":"2025-02-14","current":17.440689,"twenty":9.173384,"median":18.752272,"eighty":26.563702,"marketCap":208259269606.51},{"date":"2025-02-21","current":18.037424,"twenty":9.173384,"median":18.672846,"eighty":26.563702,"marketCap":215384882550.78},{"date":"2025-02-28","current":17.963541,"twenty":9.173384,"median":18.676064,"eighty":26.563702,"marketCap":214502647775.32},{"date":"2025-03-07","current":18.870832,"twenty":9.17305,"median":18.699973,"eighty":26.564795,"marketCap":225336612035.23},{"date":"2025-03-14","current":18.012021,"twenty":9.17305,"median":18.728326,"eighty":26.564795,"marketCap":215081544614.48},{"date":"2025-03-21","current":18.611632,"twenty":9.17305,"median":18.728326,"eighty":26.564795,"marketCap":222241493733.77},{"date":"2025-03-28","current":17.773649,"twenty":9.17305,"median":18.728326,"eighty":26.564795,"marketCap":212235145303.4},{"date":"2025-04-04","current":17.039027,"twenty":9.17305,"median":18.728326,"eighty":26.564795,"marketCap":203463019508.1}],"updateTime":1743912152533}}}